Answers are grounded in this paper and cite their sources.
The glucuronide of a new oral antidiabetic agent, (+/-)-5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl- methoxy)benzyl]thiazolidine-2,4-dione (CS-045) (1), was synthesized to confirm the structure of a metabolite in monkeys (Macaca fascicularis) and to examine its antidiabetic activity. The glucuronide also had antidiabetic activity in KK-mice.
No takes yet. Share an insight, caveat, or question.
Fujita et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: